Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lindy L. Bancke"'
Autor:
Paul Feuerstadt, Jessica R. Allegretti, Erik R. Dubberke, Amy Guo, Adam Harvey, Min Yang, Viviana Garcia-Horton, Mirko Fillbrunn, Glenn Tillotson, Lindy L. Bancke, Kerry LaPlante, Kevin W. Garey, Sahil Khanna
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 1, Pp 221-236 (2024)
Abstract Introduction Clostridioides difficile infection (CDI) causes symptoms of varying severity and negatively impacts patients’ health-related quality of life (HRQL). Despite antibiotic treatment, recurrence of CDI (rCDI) is common and imposes
Externí odkaz:
https://doaj.org/article/60bcb17d6e844671925f5267b451bedd
Autor:
Feuerstadt P; Yale School of Medicine, Division of Digestive Diseases, New Haven, CT.; PACT Gastroenterology Center, Hamden, CT., Crawford CV; Weill Cornell Medicine, New York, NY., Tan X; Ferring Pharmaceuticals, Parsippany, NJ., Pokhilko V; Ferring Pharmaceuticals, Parsippany, NJ., Bancke L; Ferring Pharmaceuticals, Roseville, MN., Ng S; Ferring Pharmaceuticals, Parsippany, NJ., Guthmueller B; Ferring Pharmaceuticals, Roseville, MN., Bidell MR; Ferring Pharmaceuticals, Parsippany, NJ., Tillotson G; GST Micro LLC, North, VA., Johnson S; Edward Hines Jr. Veterans Affairs Hospital, Department of Research and Medicine, Hines, IL.; Loyola University Medical Center, Department of Medicine, Fahey Center, Maywood, IL., Skinner AM; Edward Hines Jr. Veterans Affairs Hospital, Department of Research and Medicine, Hines, IL.; Loyola University Medical Center, Department of Medicine, Fahey Center, Maywood, IL.
Publikováno v:
Journal of clinical gastroenterology [J Clin Gastroenterol] 2024 Sep 01; Vol. 58 (8), pp. 818-824. Date of Electronic Publication: 2024 Sep 01.
Autor:
Feuerstadt P; Yale School of Medicine, New Haven, CT, USA., Chopra T; Wayne State University, Detroit, MI, USA., Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA., Van Hise NW; Metro Infectious Disease Consultants, Burr Ridge, IL, USA., Dubberke ER; Washington University School of Medicine, Saint Louis, MO, USA., Baggott B; Cleveland Clinic, Cleveland, OH, USA., Guthmueller B; Rebiotix Inc., a Ferring Company, Roseville, MN, USA., Bancke L; Rebiotix Inc., a Ferring Company, Roseville, MN, USA., Gamborg M; Ferring Pharmaceuticals, Copenhagen, Denmark., Steiner TS; Division of Infectious Diseases, University of British Columbia, Vancouver, BC, CA., Van Handel D; MNGI Digestive Health, Plymouth, MN, USA., Khanna S; Mayo Clinic, Rochester, MN, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 24. Date of Electronic Publication: 2024 Aug 24.
Autor:
Lee C; Medical Microbiologist and Researcher, Island Health, Clinical Professor, Department of Pathology and Laboratory Medicine, The University of British Columbia Faculty of Medicine, Vancouver, BC V6T 1Z3, Canada.; Island Medical Program University of British Columbia, University of Victoria, Victoria, BC, Canada., Louie T; University of Calgary and Foothills Medical Center, Calgary, AB, Canada., Bancke L; Rebiotix Inc., a Ferring Company, Roseville, MN, USA., Guthmueller B; Rebiotix Inc., a Ferring Company, Roseville, MN, USA., Harvey A; Rebiotix Inc., a Ferring Company, Roseville, MN, USA., Feuerstadt P; Yale School of Medicine, New Haven, CT, USA., Khanna S; Mayo Clinic, Rochester, MN, USA., Orenstein R; Mayo Clinic, Phoenix, AZ, USA., Dubberke ER; Washington University School of Medicine, St. Louis, MO, USA.
Publikováno v:
Therapeutic advances in gastroenterology [Therap Adv Gastroenterol] 2023 Jun 12; Vol. 16, pp. 17562848231174277. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Autor:
Feuerstadt P; Yale University School of Medicine; PACT Gastroenterology Center, Hamden, Connecticut, USA., Harvey A; Rebiotix (a Ferring Company), Roseville, Minnesota, USA., Yoho DS; Department of Gastroenterology, Mid-Atlantic Permanente Medical Group, Springfield, Virginia, USA., Garcia-Diaz JB; Department of Clinical Infectious Diseases Research and Medical Subspecialties, Ochsner Medical Center, New Orleans, Louisiana, USA., Knapple WL; Department of Gastroenterology, Arkansas Gastroenterology, North Little Rock, Arkansas, USA., Bancke L; Rebiotix (a Ferring Company), Roseville, Minnesota, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Mar 31; Vol. 10 (5), pp. ofad171. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).
Autor:
Tillotson G; Division of Microbiology, GST Micro, North, Virginia, USA., Archbald-Pannone L; Department of Internal Medicine and Infectious Diseases, University of Virginia Hospital, Charlottesville, Virginia, USA., Johnson S; Department of Infectious Diseases, Edward Hines Jr Veterans Affairs Hospital, Hines, Illinois, USA.; Loyola University Medical Center, Maywood, Illinois, USA., Ng S; Medical Affairs, Ferring Pharmaceuticals, Parsippany, New Jersey, USA., Ando M; Clinical Research Department, Ferring Pharmaceuticals, Parsippany, New Jersey, USA., Harvey A; Clinical Research Department, Rebiotix Inc, a Ferring Company, Roseville, Minnesota, USA., Bancke L; Clinical Research Department, Rebiotix Inc, a Ferring Company, Roseville, Minnesota, USA., Feuerstadt P; PACT Gastroenterology Center, Hamden, Connecticut, USA.; Division of Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2022 Dec 30; Vol. 10 (1), pp. ofac703. Date of Electronic Publication: 2022 Dec 30 (Print Publication: 2023).
Autor:
Khanna S; Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Khanna.Sahil@mayo.edu., Assi M; University of Kansas School of Medicine-Wichita, Wichita, KS, USA., Lee C; University of Victoria, Victoria, BC, Canada., Yoho D; Kaiser Permanente Springfield Medical Center, Springfield, VA, USA., Louie T; University of Calgary, Calgary, AB, Canada., Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA., Aguilar H; Louisiana Research Center, Shreveport, LA, USA., Garcia-Diaz J; Ochsner Clinic, New Orleans, LA, USA., Wang GP; University of Florida, Gainesville, FL, USA., Berry SM; Berry Consultants, LLC, Austin, TX, USA., Marion J; Berry Consultants, LLC, Austin, TX, USA., Su X; Formerly of Rebiotix, Inc, Roseville, MN, USA., Braun T; Formerly of Rebiotix, Inc, Roseville, MN, USA., Bancke L; Rebiotix, Inc, Roseville, MN, USA., Feuerstadt P; Yale School of Medicine, New Haven, CT, USA.; PACT Gastroenterology Center, Hamden, CT, USA.
Publikováno v:
Drugs [Drugs] 2022 Oct; Vol. 82 (15), pp. 1527-1538. Date of Electronic Publication: 2022 Oct 26.
Autor:
Khanna S; Gastroenterology and Hepatology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Khanna.Sahil@mayo.edu., Assi M; University of Kansas School of Medicine-Wichita, Wichita, KS, USA., Lee C; University of Victoria, Victoria, BC, Canada., Yoho D; Kaiser Permanente Springfield Medical Center, Springfield, VA, USA., Louie T; University of Calgary, Calgary, AB, Canada., Knapple W; Arkansas Gastroenterology, North Little Rock, AR, USA., Aguilar H; Louisiana Research Center, Shreveport, LA, USA., Garcia-Diaz J; Ochsner Clinic, New Orleans, LA, USA., Wang GP; University of Florida, Gainesville, FL, USA., Berry SM; Berry Consultants, LLC, Austin, TX, USA., Marion J; Berry Consultants, LLC, Austin, TX, USA., Su X; Formerly of Rebiotix, Inc, Roseville, MN, USA., Braun T; Formerly of Rebiotix, Inc, Roseville, MN, USA., Bancke L; Rebiotix, Inc, Roseville, MN, USA., Feuerstadt P; Yale School of Medicine, New Haven, CT, USA.; PACT Gastroenterology Center, Hamden, CT, USA.
Publikováno v:
Drugs [Drugs] 2022 Oct; Vol. 82 (15), pp. 1539.